Drug Type Chemical drugs |
Synonyms- |
Target |
Action antagonists |
Mechanism GPR19 antagonists(G protein-coupled receptor 19 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | United States | 30 Nov 2011 | |
Metastatic melanoma | Preclinical | United States | 30 Nov 2011 |